Research [ASAP] Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy LikeLiked Date: January 27, 2025 Less than 1 MinRead Views: 44 ACS Applied Materials & Interfaces DOI: 10.1021/acsami.4c21028 Source: http://dx.doi.org/10.1021/acsami.4c21028 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles 🌍 ESG Weekly Brief | The System Rebuild: How ESG, AI, and Infrastructure Are Redefining Global Markets Finance & investments April 17, 2026 SBTi Hits 10,000 Companies with Validated Targets in 2026: Asia Fuels the Net-Zero Momentum Carbon Markets April 17, 2026 Carbon Credit Rush: Mining Giants Rio Tinto and Woodside Turn to Offsets Under Australia’s Climate Rules Carbon Markets April 17, 2026 2026 Sustainability Green and Blue Ribbon Student Research Projects Climate & Resource April 17, 2026 Porsche 911 Turbo S gets bespoke Pirelli P Zero R Clean Tech April 17, 2026 Unibio and BioVerde co-develop methane-based manufacturing processes for sustainable chemical intermediates Clean Tech April 17, 2026 US Steel to restart Gary Tin Mill production Packaging April 17, 2026 Collaborative self-assembled enzymes and self-immobilised biofilms for enhanced biocatalytic processes Research April 17, 2026 4 Ecosystem Processes: Nutrient Cycle (Part 2) Food & Agriculture April 17, 2026 Upcycling silicon from End-of-Life photovoltaic panels to a heterogeneous catalyst for the Mizoroki–Heck cross-coupling Research April 17, 2026 Load more
